-
+91 82200 83300 +91 95000 75461
Please feel free to contact our friendly reception staff with any general enquiry.
Read More - Mobile: +91 82200 83300 | +91 95000 75461
- Email : Invest@wealthjournee.com
Assess Your Risk Tolerance
We will ask you a set of questions to get to know you!
Step 1: Describe your knowledge of investments:
Assess Your Risk Tolerance
We will ask you a set of questions to get to know you!
Step 2: When you invest your money, you are:
Assess Your Risk Tolerance
We will ask you a set of questions to get to know you!
Step 3: If the market lost 25% in the last few months, and your investments
also suffered the same - what would be your first impulse?
Assess Your Risk Tolerance
We will ask you a set of questions to get to know you!
Step 4: Have you ever invested in shares or mutual funds? If yes, for how many years?
Assess Your Risk Tolerance
We will ask you a set of questions to get to know you!
Step 5: To obtain a return of more than what you would receive
as a bank fixed deposit, you must take risks.
Assess Your Risk Tolerance
We will ask you a set of questions to get to know you!
Step 6: How do you react to the idea of investments?
Verify Email Address
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Invest Now
Fund Manager: Meeta Shetty, Rajat Srivastava |
Equity: Sectoral-Pharma and Healthcare |
NIFTY Pharma TRI
NAV as on 06-08-2025
AUM as on 30-06-2025
Rtn ( Since Inception )
12.1%
Inception Date
Dec 28, 2015
Expense Ratio
2.11%
Fund Status
Open Ended Scheme
Min. Investment
5,000
Min. Topup
1,000
Min. SIP Amount
100
Risk Status
very high
Investment Objective : The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Fund Performance
3 and 6 Months returns are absolute
NAV Movement
Returns (%)
| 3 Mon | 6 Mon | 1 Yr | 3 Yrs | 5 Yrs | 10 Yrs | |
|---|---|---|---|---|---|---|
| Fund | 3.43 | -0.19 | 4.92 | 22.23 | 18.76 | 0.0 |
| Nifty Pharma TRI | 0.38 | -1.75 | 0.52 | 19.43 | 14.39 | 6.14 |
| Equity: Sectoral-Pharma and Healthcare | 4.19 | 0.51 | 7.51 | 22.53 | 18.59 | 12.0 |
| Rank within Category | 11 | 10 | 10 | 5 | 4 | |
| Number of Funds within Category | 16 | 16 | 14 | 10 | 9 |
Peer Comparison
| Return (%) | ||||||
|---|---|---|---|---|---|---|
| Scheme Name | AUM (crore) |
Expense Ratio |
1 Yr | 3 Yrs | 5 Yrs | 10 Yrs |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 128.2 | 2.11 | 4.92 | 22.23 | 18.76 | 0.0 |
| WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth | 36.41 | 2.38 | 19.33 | 0.0 | 0.0 | 0.0 |
| HDFC Pharma and Healthcare Fund - Growth Option | 178.62 | 2.06 | 16.66 | 0.0 | 0.0 | 0.0 |
| SBI Healthcare Opportunities Fund - Regular Plan -Growth | 384.92 | 1.93 | 14.87 | 26.92 | 21.18 | 11.66 |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 572.76 | 1.89 | 10.83 | 26.73 | 21.19 | 0.0 |
| UTI Healthcare Fund - Regular Plan - Growth Option | 109.87 | 2.26 | 10.48 | 24.45 | 18.51 | 11.17 |
| LIC MF Healthcare Fund-Regular Plan-Growth | 8.77 | 2.45 | 7.73 | 18.67 | 14.39 | 0.0 |
| Kotak Healthcare Fund - Regular Plan - Growth Option | 45.34 | 2.4 | 7.08 | 0.0 | 0.0 | 0.0 |
| DSP Healthcare Fund - Regular Plan - Growth | 305.69 | 1.93 | 6.23 | 23.35 | 20.01 | 0.0 |
| Mirae Asset Healthcare Fund -Regular Growth | 278.51 | 1.93 | 5.71 | 20.35 | 18.41 | 0.0 |
Yearly Performance (%)
Historical Returns (%)
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | 0.0 | -14.65 | 4.65 | -2.62 | 5.51 | 64.38 | 19.07 | -8.04 | 36.58 | -5.3 |
| 0 | 0 | 0 | 0 | 0 | ||||||
| Equity: Sectoral-Pharma and Healthcare | - |
Returns Calculator
Growth of 10000 In SIP (Fund vs Benchmark)
Growth of 10000 In LUMPSUM (Fund vs Benchmark)
Rolling Returns
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.